Relation of statin use to the 5-year incidence and progression of age-related maculopathy

Archives of Ophthalmology

Volumn 121, Issue 8, 2003, Pages 1151-1155

  Klein, Ronald ^a,b   Klein, Barbara E K ^a   Tomany, Sandra C ^a   Danforth, Lorraine G ^a   Cruickshanks, Karen J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INCIDENCE; MALE; MEASUREMENT; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DRUG UTILIZATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; WISCONSIN;

EID: 0043063904     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.8.1151     Document Type: Article

References (30)

1. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: update findings from two clinical trials. Arch Ophthalmol. 1993;111:1200-1209.
2. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol. 2001;119:198-207.
3. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol. 2001;119:1417-1436.
4. Hall NF, Gale CR, Syddall H, Phillips DIW, Martyn CN. Risk of macular degeneration in users of statins: cross sectional study. BMJ. 2001;323:375-376.
5. McCarty CA, Mukest BN, Guymer RH, Baird PN, Taylor HR. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression [letter]. Med J Aust. 2001;175:340.
6. van Leeuwen R, Vingerling JR, de Jong PT. Risk of macular degeneration with statin use should be interpreted with caution [letter]. BMJ. 2001;323:1308.
7. Klein R, Klein BEK, Linton KLP, et al. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98:1310-1315.
8. Klein R, Klein BEK, Lee KP. The changes in visual acuity in a population: the Beaver Dam Eye Study. Ophthalmology. 1996;103:1169-1178.
9. Klein R, Klein BEK, Lee KE, et al. Changes in visual acuity in a population over a 10-year period: the Beaver Dam Eye Study. Ophthalmology. 2001;108:1757-1766.
10. Klein R, Klein BEK. Beaver Dam Eye Study: Manual of Operations. Springfield, Va: US Dept of Commerce; 1991. National Technical Information Service Accession No. PB 91-149823.
11. Klein R, Klein BEK. Beaver Dam Eye Study II: Manual of Operations. Springfield, Va: US Dept of Commerce; 1995. National Technical Information Service Accession No. PB 95-273827.
12. American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2000.
13. Hypertension Detection and Follow-up Program Cooperative Group. The hypertension detection and follow-up program. Prev Med. 1976;5:207-215.
14. Allain CC, Poon LS, Chan CGS, et al. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
15. Lopes-Virella MF, Stone P, Ellis S, et al. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 1977;23:882-884.
16. Klein R, Davis MD, Magli YL, et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991;98:1128-1134.
17. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
18. Klein R, Klein BEK, Jensen SC, et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7-21.
19. Klein R, Klein BEK, Moss SE. The relation of smoking to the incidence of age-related maculopathy. Am J Epidemiol. 1998;147:103-110.
20. SAS/STAT: User's Guide: Version 8. Cary, NC: SAS Institute Inc, 1999.
21. Hosmer DW Jr, Lemeshow S. In: Hosmer DW Jr, Lemeshow S, eds. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989:238-245.
22. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy. Arch Ophthalmol. 2001;119:1455-1462.
23. Delcourt C, Michel F, Colvezx A, Lacroux A, Delage M, Vernet MH. Associations of cardiovascular disease and its risk factors with age-related macular degneration: the POLA study. Ophthalmic Epidemiol. 2001;8:237-249.
24. Klein R, Klein BEK, Jensen SC, Cruickshanks JK, et al. Medication use and the 5-year incidence of early age-related maculopathy. Arch Ophthalmol. 2001;119:1354-1359.
25. van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospctive cohort study with cumulative exposure measurement BMJ. 2003;326:255-256.
26. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology. 2001;108:705-710
27. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
28. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:265-274.
29. Klein R. Epidemiology. In: Berger JW, Fine SL, Maguire MG, eds. Age-related Macular Degeneration. St Louis, Mo: Mosby-Year Book Inc; 1999:31-55.
30. Klein R, Klein BEK, Marino EK, et al. Age-related maculopathy in the Cardiovascular Health Study. Ophthalmology. 2003;110:25-33.